| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |